Eli Lilly and Co
Here are 3 major moments that drove the stock market last week
A massive market snapback on Friday couldn’t erase all of the week’s damage. After several days of selling, the tech sector roared back, with the Nasdaq gaining over 2% on Friday. Chipmakers Nvidia and Broadcom led the way, with gains of 7.8% and 7.2%, respectively. The broad-based S & P 500 rose nearly 2% in […]
Read More
Stocks making the biggest moves midday: Amazon, Centene, Roblox and more
Check out the companies making headlines in midday trading. Centene — Shares of the health insurance provider slid 5%. Guidance for full-year revenue came in at $186.5 billion to $190.5 billion, missing the FactSet consensus call for $194.1 billion. The outlook for premium and service revenue for the year was also shy of Wall Street […]
Read More
Stocks making the biggest moves premarket: Amazon, Reddit, Strategy, Molina, Strategy, Eli Lilly & more
Check out the companies making headlines before the bell. Amazon — Shares tumbled 7% after the ecommerce giant reported $1.95 in earnings per share in the fourth quarter, narrowly missing the consensus forecast of $1.97 per share from analysts polled by LSEG. Amazon also said to expect $200 billion in capital expenditures for 2026. Molina […]
Read More
Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early Friday after a legal threat from Novo Nordisk. The online teleheath company announced on Thursday plans to launch a cheaper, copycat version of Novo’s weight loss pill, prompting Novo to take legal action. Hims stock spiked as […]
Read More
The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]
Read More
Jim Cramer spots 2 stocks to buy as market drops for a third straight day
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1. Stocks are down on Thursday, following a volatile session that saw a sell-off in software stocks. Big Tech is broadly lower, with Alphabet down 4.3% and Amazon , which […]
Read More
Novo Nordisk and Eli Lilly tumble after Hims & Hers announce $49 copy of Wegovy pill
Weight-loss drugmakers Eli Lilly and Novo Nordisk tumbled after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Copenhagen-listed shares of Novo dropped as much as 9% on the news, while Eli Lilly […]
Read More
Jim Cramer says the tech sell-off proves why this old investing rule still matters
The action on Wall Street this week is a reminder of the importance of portfolio diversification, CNBC’s Jim Cramer said Wednesday, as tech-only portfolios have been getting beaten down during the bout of volatility. “Tech’s a good part of the market, it’s just that many of these stocks suddenly aren’t worth as much as we […]
Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market. Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]
Read More
Jim Cramer says the software sell-off creates opportunities in stocks outside of tech
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. Stocks were attempting to shake off continued fears that AI disruption could undermine traditional enterprise software companies. Some of the high-multiple names hit hardest in recent sessions, including Club […]
Read More